Remove topic dementia
article thumbnail

Exploring the importance we play in our own health maintenance – a pharmaphorum podcast extra

pharmaphorum

While at Anthropy 2022, pharmaphorum’s web editor Nicole Raleigh briefly spoke with Karyn Johnston, chief executive of East Cheshire Hospice, who had taken part in the Adelphi Group’s panel, ‘Later life care and dementia’.

52
article thumbnail

Can Antiviral Herpes Drugs Reduce the Risk of Alzheimer Disease?

The People's Pharmacy

There are few more devastating diagnoses than dementia. Epidemiological data from Taiwan show that people with a history of herpes are more likely to develop dementia. Those who took antiviral medications had a “decreased risk of dementia” ( Neurotherapeutics , April, 2018 ). No one knows, but the prospect is super scary.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Eisai forges alliance with FCNT on digital tools for dementia

pharmaphorum

Japanese drugmaker Eisai has teamed up with Fujitsu spin-out FCNT, which makes smartphones aimed at older consumers, on digital tools to support people with dementia. The post Eisai forges alliance with FCNT on digital tools for dementia appeared first on. The network already has 2.4

58
article thumbnail

Tap Native Unveils the Top 20 Most Popular Health Topics of 2021

Pharma Marketing Network

NEW YORK, December 6 th , 2021 (PRNEWSWIRE) – Tap Native, the leading health-focused content discovery platform, today unveiled a list of the top 20 most popular health topics viewed by consumer audiences in 2021. million unique URLs across the top 100 largest health websites in its network to determine which topics were viewed most.

article thumbnail

Welcome to 1st Rare & Genetic Neurodegenerative Drug Development Summit

pharmaphorum

Eli Lilly is investing $700M into genetic medicine, announcing plans to establish a Boston research center, and with the acquisition of Prevail Therapeutics in late 2020, Lilly secured access to two gene therapies that had already advanced into human testing — with one targeting Parkinson’s disease and the other, dementia.

52
article thumbnail

Protein misfolding specialist Gain nets $40m from IPO

pharmaphorum

Protein misfolding has become a hot topic in the biopharma industry, with a clutch of emerging companies targeting the broad range of diseases that feature aberrant proteins.

103
103
article thumbnail

Donepezil alternatives: What can I take instead of donepezil?

The Checkup by Singlecare

The treatment of Alzheimer’s disease is garnering more attention and capturing headlines as the prevalence of dementia in older adults climbs. Boosting acetylcholine levels can offset the deficit in the brains of those with Alzheimer’s dementia. Alzheimer’s disease, Parkinson’s disease-related dementia. Alzheimer’s disease.

Dosage 52